Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Super Bowel Cleansing Solution (XT-0008) is an osmotic laxative developed by Xi'an Xintong Pharmaceutical Research Co., Ltd. for bowel preparation prior to colonoscopy, imaging, or surgical procedures. It is a compound formulation consisting of polyethylene glycol (PEG) 4000 and a balanced blend of electrolytes, including sodium sulfate, sodium bicarbonate, sodium chloride, and potassium chloride. The mechanism of action relies on the osmotic properties of PEG, a high-molecular-weight polymer that remains in the intestinal lumen, binding water molecules and increasing the liquid volume of the stool. This expansion of volume stimulates intestinal peristalsis, leading to effective evacuation of the colon. The inclusion of electrolytes is designed to minimize the net exchange of ions across the intestinal wall, thereby maintaining fluid and electrolyte homeostasis during the cleansing process. It was approved in China under the brand name Supeiqing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polyethylene glycol 4000 + sodium sulfate + sodium bicarbonate + sodium chloride + potassium chloride.